nach oben

Erschienen in:

2023 | Multiresistente Erreger | OriginalPaper | Buchkapitel

5. Methicillinresistenter Staphylococcus aureus (MRSA)

verfasst von : Alik Dawson, Sebastian Schulz-Stübner

Erschienen in: Multiresistente Erreger

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieses Kapitel beschreibt die Epidemiologie und klinische Bedeutung von Methicillin-resistenten Staphylococcus aureus (MRSA) und erläutert die sinnvolle Diagnostik, Screening- und Dekolonisationsverfahren sowie die Diskussion um Präventionsstrategien je nach epidemiologischer Grundsituation.

Ammerlaan HS, Kluytmans JA, Wertheim HF et al (2009) Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 48(7):922–930PubMedCrossRef

Baba T, Takeuchi F, Kuroda M et al (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359(9320):1819–1827PubMedCrossRef

Bai AD, Lo CK, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, Loeb M, Lee TC (2022) Staphylococcus aureus bacteremia mortality: a systematic review and meta-analysis. Clin Microbiol Infect Mar 23:S1198-743X(22)00154-9. https://doi.org/10.1016/j.cmi.2022.03.015. Epub ahead of print. PMID: 35339678CrossRef

Becker K et al (2013) Teil: 6. Infektionen der Haut und der subkutanen Weichgewebe. Mikrobiologisch-infektiologische Qualitätsstandards. Urban & Fischer, München

Becker K, van Alen S, Idelevich EA, Schleimer N, Seggewiß J, Mellmann A, Kaspar U, Peters G (2018) Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus. Emerg Infect Dis 24(2):242–248. https://doi.org/10.3201/eid2402.171074. PMID: 29350135; PMCID: PMC5782906CrossRefPubMedPubMedCentral

Brown NM, Brown EM, Guideline Development Group (2021) Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. J Antimicrob Chemother 76(6):1377–1378. https://doi.org/10.1093/jac/dkab036. PMID: 33582806CrossRefPubMed

Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus – Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 48(32):707–710

Climo MW, Yokoe DS, Warren DK et al (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368(6):533–542PubMedPubMedCentralCrossRef

Cosgrove SE, Sakoulas G, Perencevich EN et al (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36(1):53–59PubMedCrossRef

Creamer E, Galvin S, Dolan A et al (2012) Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital. Am J Infect Control 40(5):411–415PubMedCrossRef

Cui L, Tominaga E, Neoh HM, Hiramatsu K (2006) Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate staphylococcus aureus. Antimicrob Agents Chemother 50(3):1079–1082PubMedPubMedCentralCrossRef

Cuny C, Kock R, Witte W (2013) Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany. Int J Med Microbiol 303(6–7):331–337PubMedCrossRef

Davis KA, Stewart JJ, Crouch HK et al (2004) Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39(6):776–782PubMedCrossRef

DeLeo FR, Chambers HF (2009) Reemergence of antibiotic-resistant staphylococcus aureus in the genomics era. J Clin Invest 119(9):2464–2474PubMedPubMedCentralCrossRef

DeLeo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375(9725):1557–1568PubMedPubMedCentralCrossRef

Deneke C, Uelze L, Brendebach H, Tausch SH, Malorny B (2021) Decentralized Investigation of Bacterial Outbreaks Based on Hashed cgMLST. Front Microbiol 12:649517. https://doi.org/10.3389/fmicb.2021.649517. PMID: 34220740; PMCID: PMC8244591CrossRefPubMedPubMedCentral

Derde LP, Cooper BS, Goossens H et al (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14(1):31–39PubMedPubMedCentralCrossRef

Dufour P, Gillet Y, Bes M et al (2002) Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35(7):819–824PubMedCrossRef

von Eiff C, Becker K, Machka K et al (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group N Engl J Med 344(1):11–16CrossRef

Enright MC, Robinson DA, Randle G et al (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99(11):7687–7692PubMedPubMedCentralCrossRef

Farbman L, Avni T, Rubinovitch B et al (2013) Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review. Clin Microbiol Infect 19(12):E582–E593PubMedCrossRef

Fätkenheuer G, Hirschel B, Harbarth S (2015) Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 385(9973):1146–1149PubMedCrossRef

Forster AJ, Oake N, Roth V et al (2013) Patient-level factors associated with methicillin-resistant Staphylococcus aureus carriage at hospital admission: a systematic review. Am J Infect Control 41(3):214–220PubMedCrossRef

Friaes A, Resina C, Manuel V et al (2014) Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus infection in Europe. Epidemiol Infect 143:745–748PubMedPubMedCentralCrossRef

Fridkin SK, Hageman JC, Morrison M, Active Bacterial Core Surveillance Program of the Emerging Infections Program et al (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352(14):1436–1444PubMedCrossRef

Friedrich AW, Daniels-Haardt I, Kock R et al (2008) EUREGIO MRSA-net Twente/Munsterland – a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus. Euro Surveill 13(35):18965PubMedCrossRef

Garcia-Alvarez L, Holden MT, Lindsay H et al (2011) Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 11(8):595–603PubMedPubMedCentralCrossRef

GERMAP (2012) Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. https://www.bvl.bund.de/SharedDocs/Downloads/05_Tierarzneimittel/germap2012.pdf?__blob=publicationFile&v=5 (letzter Zugriff 15.12.2022)

GERMAP (2015) Antibiotika-Resistenz und -Verbrauch. https://www.dzif.de/system/files/document/GERMAP-2015deutsch.pdf (letzter Zugriff 15.12.2022)

Gosbell IB, Mercer JL, Neville SA et al (2001) Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust 174(12):627–630PubMedCrossRef

Grundmann H, Aanensen DM, van den Wijngaard CC, European Staphylococcal Reference Laboratory Working et al (2010) Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 7(1):e1000215PubMedPubMedCentralCrossRef

Gurieva TV, Bootsma MC, Bonten MJ (2012) Decolonization of patients and health care workers to control nosocomial spread of methicillin-resistant Staphylococcus aureus: a simulation study. BMC Infect Dis 12:302PubMedPubMedCentralCrossRef

van Hal SJ, Jensen SO, Vaska VL et al (2012) Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev 25(2):362–386PubMedPubMedCentralCrossRef

Harbarth S, Masuet-Aumatell C, Schrenzel J et al (2006) Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 10(1):R25PubMedPubMedCentralCrossRef

Harmsen D, Claus H, Vogel U (2005) DNA sequence-based tandem repeat analysis of the clfB gene is less discriminatory than spa typing for methicillin-resistant Staphylococcus aureus. Int J Med Microbiol 294(8):525–528PubMedCrossRef

Hernandez D, Francois P, Farinelli L et al (2008) De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. Genome Res 18(5):802–809PubMedPubMedCentralCrossRef

Herrmann M, Petit C, Dawson A et al (2013) Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening study. PLoS One 8(9):e73876PubMedPubMedCentralCrossRef

Hetem DJ, Bonten MJ (2013) Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 85(4):249–256PubMedCrossRef

Hiramatsu K, Ito T, Tsubakishita S et al (2013) Genomic basis for methicillin resistance in staphylococcus aureus. Infect Chemother 45(2):117–136PubMedPubMedCentralCrossRef

Huang SS, Septimus E, Kleinman K, Network and P. Healthcare-Associated Infections et al (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368(24):2255–2265PubMedCrossRef

Humphries RM, Pollett S, Sakoulas G (2013) A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev 26(4):759–780PubMedPubMedCentralCrossRef

Jog S, Cunningham R, Cooper S et al (2008) Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 69(2):124–130PubMedCrossRef

Johnson AP (2011) Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother 66(Suppl 4):iv43–iv48PubMed

Katayama Y, Ito T, Hiramatsu K (2000) A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 44(6):1549–1555PubMedPubMedCentralCrossRef

Kim C, Milheirico C, Gardete S et al (2012) Properties of a novel PBP2A protein homolog from Staphylococcus aureus strain LGA251 and its contribution to the beta-lactam-resistant phenotype. J Biol Chem 287(44):36854–36863PubMedPubMedCentralCrossRef

Köck R (2013) Zum Aufwand von MRSA-Screeninguntersuchungen in deutschen Krankenhäusern. Epidemiol Bull 5:41–44

Köck R, Mellmann A, Schaumburg F et al (2011) Methicillin-resistenter Staphylococcus aureus in Deutschland: Epidemiologie. Dtsch Arztebl Int 108(45):761–767PubMedPubMedCentral

Kommission für Krankenhaushygiene und Infektionsprävention (1999) Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Bundesgesundheitsbl 42:954–958CrossRef

Kommission für Krankenhaushygiene und Infektionsprävention (2014) Empfehlungen zur Prävention und Kontrolle von Methicillinresistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsbl 57:696–732

Koser CU, Ellington MJ, Cartwright EJ et al (2012) Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog 8(8):e1002824PubMedPubMedCentralCrossRef

Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130PubMedPubMedCentralCrossRef

Kresken M, Hafner D, Körber-Irrgang B für die Studiengruppe Epidemiologie und Resistenzsituation bei klinisch wichtigen Infektionserregern aus dem ambulanten Versorgungsbereich gegenüber Antibiotika (2013) Bericht über die Ergebnisse einer multizentrischen Studie der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. Antiinfectives Intelligence, Rheinbach

Layer F (2013) Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland – Update 2011/2012. Epidemiol Bull 27(21):187–193

Layer F, Strommenger B, Cuny C, Werner G (2021) Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland – Zur Situation 2019/2020. Epidemiol Bull 40:3–12. https://doi.org/10.25646/9007CrossRef

Lee AS, Huttner B, Harbarth S (2011a) Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin N Am 25(1):155–179CrossRef

Lee AS, Macedo-Vinas M, Francois P et al (2011b) Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect 77(4):360–362PubMedCrossRef

Lemmen S, Podbielski A, Fätkenheuer G, Mattner F (2014) Infektionsprävention bei Intensivpatienten: Dekolonisierung ist eine gute Strategie. Dtsch Arztebl Int 111(38):A-1565–A-1566

Lim D, Strynadka NC (2002) Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat Struct Biol 9(11):870–876PubMed

Locke JB, Zuill DE, Scharn CR et al (2014) Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene. Antimicrob Agents Chemother 58(11):6592–6598PubMedPubMedCentralCrossRef

Loeb MB, Main C, Eady A, Walker-Dilks C (2003) Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 4:CD003340

Ma XX, Ito T, Tiensasitorn C et al (2002) Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46(4):1147–1152PubMedPubMedCentralCrossRef

McAdam PR, Templeton KE, Edwards GF et al (2012) Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 109(23):9107–9112PubMedPubMedCentralCrossRef

McKinnell JA, Huang SS, Eells SJ et al (2013) Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34(2):161–170PubMedCrossRef

Meka VG, Gold HS (2004) Antimicrobial resistance to linezolid. Clin Infect Dis 39(7):1010–1015PubMedCrossRef

Mest DR, Wong DH, Shimoda KJ et al (1994) Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 78(4):644–650PubMedCrossRef

Mielke M, Friedrich AW (2014) Infektionen mit mehrfachresistenten Bakterien: Die Rolle von regionalen MRE-Netzwerken zur Vermeidung der Weiterverbreitung. Hyg Med 39:477–480

Monecke S, Coombs G, Shore AC et al (2011) A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4):e17936PubMedPubMedCentralCrossRef

Murthy A, De Angelis G, Pittet D et al (2010) Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect 16(12):1747–1753PubMedCrossRef

Noto MJ, Domenico HJ, Byrne DW et al (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313(4):369–378PubMedPubMedCentralCrossRef

Nubel U, Strommenger B, Layer F, Witte W (2011) From types to trees: reconstructing the spatial spread of Staphylococcus aureus based on DNA variation. Int J Med Microbiol 301(8):614–618PubMedCrossRef

Park HJ, Kim SH, Kim MJ, Lee YM, Park SY, Moon SM, Park KH, Chong YP, Lee SO, Choi SH, Woo JH, Kim YS (2009) Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 49:395–401PubMedCrossRef

Patel D, Husain M, Vidaillac C et al (2011) Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. Int J Antimicrob Agents 38(5):442–446PubMedCrossRef

Peterson LR, Hacek DM, Robicsek A (2007) 5 million lives campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Saf 33(12):732–738PubMed

Reich-Schupke S, Warneke K, Altmeyer P, Stucker M (2010) Eradication of MRSA in chronic wounds of outpatients with leg ulcers is accelerated by antiseptic washes – results of a pilot study. Int J Hyg Environ Health 213(2):88–92PubMedCrossRef

Ridgway JP, Peterson LR, Brown EC et al (2013) Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk. PLoS One 8(11):e79716PubMedPubMedCentralCrossRef

Robicsek A, Beaumont JL, Paule SM et al (2008) Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148(6):409–418PubMedCrossRef

Roche FM, Meehan M, Foster TJ (2003) The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 149(Pt 10):2759–2767PubMedCrossRef

Rybak MJ, Le J, Lodise TP, Levine DP et al (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77(11):835–864. https://doi.org/10.1093/ajhp/zxaa036. PMID: 32191793CrossRefPubMed

Salgado CD, Farr BM (2006) What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol 27(2):116–121PubMedCrossRef

Sandri AM, Dalarosa MG, Ruschel de Alcantara L et al (2006) Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27(2):185–187PubMedCrossRef

Sanford MD, Widmer AF, Bale MJ et al (1994) Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 19(6):1123–1128PubMedCrossRef

Sauvage E, Duez C, Herman R et al (2007) Crystal structure of the Bacillus subtilis penicillin-binding protein 4a, and its complex with a peptidoglycan mimetic peptide. J Mol Biol 371(2):528–539PubMedCrossRef

Schwendener S, Cotting K, Perreten V (2017) Novel methicillin resistance gene mecD in clinical Macrococcus caseolyticus strains from bovine and canine sources. Sci Rep 7:43797. https://doi.org/10.1038/srep43797CrossRefPubMedPubMedCentral

Shore AC, Coleman DC (2013) Staphylococcal cassette chromosome mec: recent advances and new insights. Int J Med Microbiol 303(6–7):350–359PubMedCrossRef

Sommer A, Fuchs S, Layer F, Schaudinn C, Weber RE, Hugues R, Erdmann MB, Laue M, Schuster CF, Werner G, Strommenger B (2021) Mutations in the gdpP gene are a clinically relevant mechanism for β-lactam resistance in methicillin resistant Staphylococcus aureus lacking mec determinants. Microbial. Genomics 7(9). https://doi.org/10.1099/mgen.0.000623

Stefani S, Chung DR, Lindsay JA et al (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 39(4):273–282PubMedCrossRef

Stegger M, Wirth T, Andersen PS et al (2014) Origin and evolution of European community-acquired methicillin-resistant Staphylococcus aureus. MBio 5(5):e01044–e01014PubMedPubMedCentralCrossRef

Stenehjem E, Rimland D (2013) MRSA nasal colonization burden and risk of MRSA infection. Am J Infect Control 41(5):405–410PubMedCrossRef

Strommenger B, Kettlitz C, Weniger T et al (2006) Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol 44(7):2533–2540PubMedPubMedCentralCrossRef

Struelens MJ, Hawkey PM, French GL et al (2009) Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect 15(2):112–119PubMedCrossRef

Tacconelli E, De Angelis G, de Waure C et al (2009) Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 9(9):546–554PubMedCrossRef

Talan DA, Moran GJ, Krishnadasan A et al (2018) Subgroup analysis of antibiotic treatment for skin abscesses. Ann Emerg Med 71:21–30PubMedCrossRef

Udo EE (2013) Community-acquired methicillin-resistant Staphylococcus aureus: the new face of an old foe? Med Princ Pract 22(Suppl 1):20–29PubMedPubMedCentralCrossRef

Udo EE, Sarkhoo E (2010) Genetic analysis of high-level mupirocin resistance in the ST80 clone of community-associated meticillin-resistant Staphylococcus aureus. J Med Microbiol 59(Pt 2):193–199PubMedCrossRef

Udo EE, Pearman JW, Grubb WB (1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 25(2):97–108PubMedCrossRef

Vivoni AM, Santos KR, de Oliveira MP et al (2005) Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol 26(7):662–667PubMedCrossRef

Voss A, Loeffen F, Bakker J et al (2005) Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 11(12):1965–1966PubMedPubMedCentralCrossRef

Walsh EJ, O’Brien LM, Liang X et al (2004) Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem 279(49):50691–50699PubMedCrossRef

Wang X, Panchanathan S, Chowell G (2013) A data-driven mathematical model of CA-MRSA transmission among age groups: evaluating the effect of control interventions. PLoS Comput Biol 9(11):e1003328PubMedPubMedCentralCrossRef

Warnke P, Frickmann H, Ottl P, Podbielski A (2014a) Nasal screening for MRSA: different swabs – different results! PLoS One 9(10):e111627PubMedPubMedCentralCrossRef

Warnke P, Harnack T, Ottl P et al (2014b) Nasal screening for Staphylococcus aureus – daily routine with improvement potentials. PLoS One 9(2):e89667PubMedPubMedCentralCrossRef

Warnke P, Warning L, Podbielski A (2014c) Some are more equal – a comparative study on swab uptake and release of bacterial suspensions. PLoS One 9(7):e102215PubMedPubMedCentralCrossRef

Weidenmaier C, Kokai-Kun JF, Kristian SA et al (2004) Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10(3):243–245PubMedCrossRef

Wertheim HF, Melles DC, Vos MC et al (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5(12):751–762PubMedCrossRef

Wilcox MH, Hall J, Pike H et al (2003) Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 54(3):196–201PubMedCrossRef

Wu S, Piscitelli C, de Lencastre H, Tomasz A (1996) Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb Drug Resist 2(4):435–441PubMedCrossRef

Wyllie DH, Walker AS, Miller R et al (2011) Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification. BMJ Open 1(1):e000160PubMedPubMedCentralCrossRef

Titel: Methicillinresistenter Staphylococcus aureus (MRSA)
verfasst von: Alik Dawson
Sebastian Schulz-Stübner
Verlag: Springer Berlin Heidelberg
Buch: Multiresistente Erreger
Print ISBN: 978-3-662-65707-2

Electronic ISBN: 978-3-662-65708-9

Copyright-Jahr: 2023
DOI: https://doi.org/10.1007/978-3-662-65708-9_5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen